STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling Pathways.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27780205)

Published in PLoS Biol on October 25, 2016

Authors

Johnathan Ho1, Christin Pelzel1, Andreas Begitt1, Maureen Mee1, Hany M Elsheikha2, David J Scott3,4,5, Uwe Vinkemeier1

Author Affiliations

1: School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
2: School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom.
3: ISIS Spallation Neutron and Muon Source, Rutherford Appleton Laboratory, Didcot, United Kingdom.
4: Research Complex at Harwell, Rutherford Appleton Laboratory, Didcot, United Kingdom.
5: School of Biosciences, University of Nottingham, Nottingham, United Kingdom.

Articles cited by this

Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol (2002) 15.33

Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol (2003) 12.34

T-helper-1-cell cytokines drive cancer into senescence. Nature (2013) 4.47

The JAK-STAT pathway at twenty. Immunity (2012) 4.41

Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell (1998) 3.79

The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci U S A (1992) 3.74

Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature (1993) 3.73

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med (2011) 3.63

Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol Cell Biol (1989) 3.49

STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med (2011) 3.11

Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem (1993) 2.96

DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem (2000) 2.90

JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity (2012) 2.85

Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol (2003) 2.44

Immune response in Stat2 knockout mice. Immunity (2000) 2.37

Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science (1995) 2.25

Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell (2005) 2.05

Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe (2014) 2.00

Structure of the amino-terminal protein interaction domain of STAT-4. Science (1998) 2.00

Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5. J Biol Chem (2002) 1.86

Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol (2002) 1.83

Isolation of mouse peritoneal cavity cells. J Vis Exp (2010) 1.79

Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J Biol Chem (2001) 1.68

Studies on the specificity of killing of intracellular pathogens by macrophages. Cell Immunol (1977) 1.61

Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Natl Acad Sci U S A (2008) 1.45

Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol (2010) 1.40

Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms. FEBS Lett (2004) 1.35

Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res (2002) 1.34

STAT2 nuclear trafficking. J Biol Chem (2004) 1.30

Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev (2000) 1.28

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation. Blood (2003) 1.27

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J (2013) 1.26

Getting the message across, STAT! Design principles of a molecular signaling circuit. J Cell Biol (2004) 1.25

Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol (2011) 1.15

Molecular basis for the recognition of phosphorylated STAT1 by importin alpha5. J Mol Biol (2010) 1.12

SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ. Blood (2011) 1.08

A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells. J Immunol (2010) 1.04

STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci U S A (2013) 1.01

Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity. Immunity (2015) 0.95

Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways. PLoS Pathog (2013) 0.94

STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling. Nat Immunol (2014) 0.93

Generally applicable methods to purify intracellular coccidia from cell cultures and to quantify purification efficacy using quantitative PCR. Vet Parasitol (2005) 0.92

Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med (2015) 0.90

Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res (2015) 0.90

Interpreting mixed signals: the cell's cytokine conundrum. Curr Opin Immunol (2011) 0.88

IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export. J Cell Sci (2006) 0.88

Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis. Haematologica (2013) 0.87

STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway. J Biosci (2012) 0.87

Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells. Proc Natl Acad Sci U S A (2015) 0.87

STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity. Mol Cell Biol (2014) 0.86

Stat2 loss leads to cytokine-independent, cell-mediated lethality in LPS-induced sepsis. Proc Natl Acad Sci U S A (2013) 0.86

Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domain. Cell Commun Signal (2013) 0.85

The role of signal transducer and activator of transcription-2 in the interferon response. J Interferon Cytokine Res (2012) 0.84

Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins. Immunol Rev (2015) 0.83

Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1. EMBO Rep (2016) 0.81

Evidence against a role for β-arrestin1 in STAT1 dephosphorylation and the inhibition of interferon-γ signaling. Mol Cell (2013) 0.77